IP Library Patent Application 11525433
Patent Application
App. No. 11/525,433

Lipodissolving dermatological topical preparation

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/525,433
Abstract

A dermatological topical preparation such as a cream, a lotion, an emulsion, a paste, an ointment and the likes where a lipo-dissolving emulsifier such as a biliary compound is transdermally delivered through the superficial layers of the skin into the subcutaneous adipose tissue with the use of skin permeability enhancers. Some of these skin permeability enhancers are cyclodextrins, while others are substances which have the peculiar property of enhancing delivery of the lipo-dissolving substance locally into the adipose subcutaneous tissue maximizing subcutaneous uptake while minimizing systemic absorption in order to achieve maximization of local effect.

Claims (18)

1 . A topical dermatological preparation for subcutaneous fat tissue treatment comprising:

a lipo-dissolving emulsifier, and

a cyclodextrin permeability enhancer, wherein said cyclodextrin permeability enhancer enhances skin permeability to said lipo-issolving emulsifier.

2 . The topical dermatological preparation for subcutaneous fat tissue treatment of claim 1 wherein said lipo-dissolving emulsifier is a biliary compound.

3 . The topical dermatological preparation for subcutaneous fat tissue treatment of claim 2 wherein said lipo-dissolving emulsifier is deoxycholic acid.

4 . A topical dermatological preparation for subcutaneous fat tissue treatment comprising:

a lipo-dissolving emulsifier, and

a skin permeability enhancer, wherein said skin permeability enhancer enhances skin permeability to said emulsifier and maximizes local effect of said emulsifier on subcutaneous fat tissue by maximizing accumulation of said emulsifier into the subcutaneous fat tissue while minimizing systemic absorption.

5 . The topical dermatological preparation for subcutaneous fat tissue treatment of claim 4 wherein said skin permeability enhancer is a mixture of Benzyl Alcohol, Acetone and Isopropanol.

6 . The topical dermatological preparation for subcutaneous fat tissue treatment of claim 4 wherein said lipo-issolving emulsifier is a biliary compound.

7 . The topical dermatological preparation for subcutaneous fat tissue treatment of claim 6 wherein said skin permeability enhancer is a mixture of Benzyl Alcohol, Acetone and Isopropanol.

8 . The topical dermatological preparation for subcutaneous fat tissue treatment of claim 4 wherein said lipo-dissolving emulsifier is deoxycholic acid.

9 . The topical dermatological preparation for subcutaneous fat tissue treatment of claim 6 wherein said skin permeability enhancer is a mixture of Benzyl Alcohol, Acetone and Isopropanol.

10 . The topical dermatological preparation for subcutaneous fat tissue treatment of claim 4 wherein said lipo-dissolving emulsifier is a salt of deoxycholic acid.

11 . The topical dermatological preparation for subcutaneous fat tissue treatment of claim 6 wherein said skin permeability enhancer is a mixture of Benzyl Alcohol, Acetone and Isopropanol.

12 . A topical dermatological preparation for subcutaneous fat tissue treatment comprising:

a lipo-issolving substance, and

a cyclodextrin permeability enhancer, wherein said cyclodextrin permeability enhancer enhances skin permeability to said lipo-issolving substance.

Assignments (2)
CHANGE OF NAME Recorded Aug 9, 2010
From: Z&Z MEDICAL HOLDINGS, INC.
To: ATHERONOVA OPERATIONS, INC.
Reel/Frame 024809/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2007
From: ZADINI, FILIBERTO P.; ZADINI, GIORGIO C.
To: Z & Z MEDICAL HOLDINGS, INC.
Reel/Frame 020183/0418 →